A lifesaver with a catch: Powerful new cancer drugs can trigger diabetes — and no one is certain why
Elie Dolgin • May 29, 2019
Researchers aim identify the root causes of drug-induced diabetes among cancer patients, and then to develop new therapeutic strategies for preventing diabetic complications.
Continue reading at STAT.
With organoids, assembloids and a growing bioengineering toolkit, scientists are pushing the limits of human brain models.
Drug makers are scrambling to navigate an ‘existential threat’ to a once-celebrated technology.